Investing Ideas
/
Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

2 new

Companies with a Value score of at least 3, ordered by Value score

32 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
GXI Gerresheimer	CHF 75.60	0%	0%	CHF 2.3b	CHF 122.82	PE20.5x	E21.8%	1.8%
TEVA Teva Pharmaceutical Industries	CHF 7.85	0%	0%	CHF 18.6b	CHF 10.69	PS1.1x	E65.8%	0%
SDZ Sandoz Group	CHF 42.64	1.6%	43.1%	CHF 18.7b	CHF 44.29	PS2x	E30.0%	1.0%
NOVN Novartis	CHF 93.44	4.1%	4.5%	CHF 186.8b	CHF 102.18	PE17.5x	E7.3%	3.5%
001102657 GSK	CHF 26.12	0%	-2.8%	CHF 70.6b	CHF 34.09	PE13.8x	E8.9%	5.7%
RO Roche Holding	CHF 299.40	2.8%	14.4%	CHF 225.7b	CHF 322.76	PE21.1x	E10.3%	3.4%
ROG Roche Holding	CHF 280.80	2.6%	13.6%	CHF 225.7b	CHF 302.71	PE21.1x	E10.3%	3.4%
BMY Bristol-Myers Squibb	CHF 54.24	0%	0%	CHF 100.3b	CHF 58.46	PS2.2x	E49.0%	4.8%
BAYN Bayer	CHF 67.99	0%	-66.0%	CHF 19.3b	CHF 97.14	PS0.4x	E43.3%	0.6%
COPN Cosmo Pharmaceuticals	CHF 65.30	-0.2%	2.0%	CHF 1.0b	CHF 98.37	PE15.9x	E21.5%	2.9%
JCARE Joincare Pharmaceutical Group IndustryLtd	US$8.00	0%	0%	US$20.4b	US$10.17	PE13.9x	E12.5%	1.7%
2HQ Tilray Brands	CHF 46.28	0%	0%	CHF 1.0b	CHF 77.43	PS1.2x	E76.7%	n/a
010683053 Merck	CHF 88.75	1.7%	-15.8%	CHF 246.5b	CHF 113.01	PE20.3x	E12.0%	3.3%
NOVNEE Novartis	CHF 93.57	4.1%	3.4%	CHF 186.8b	CHF 102.32	PE17.5x	E7.3%	3.5%
J7Z Jazz Pharmaceuticals	CHF 112.75	0%	n/a	CHF 7.5b	CHF 164.27	PE16.2x	E11.8%	n/a
XLS Xlife Sciences	CHF 21.10	-8.7%	-57.7%	CHF 120.6m	n/a	PE5.7x	n/a	n/a
000935700 Gilead Sciences	CHF 68.48	0%	10.5%	CHF 94.1b	CHF 82.84	PE17.2x	E7.8%	4.0%
QIA Qiagen	CHF 50.36	0%	0%	CHF 9.2b	CHF 61.37	PE27x	E11.3%	n/a
EVT Evotec	CHF 27.76	0%	0%	CHF 1.9b	CHF 29.26	PS2.4x	E74.2%	n/a
BIIB Biogen	CHF 222.00	0%	0%	CHF 27.0b	CHF 320.85	PE23.3x	E17.1%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 15.24	-8.3%	61.4%	CHF 190.7m	CHF 25.00	PE3x	S-74.4%	n/a
000982352 AstraZeneca	CHF 128.11	1.7%	11.9%	CHF 174.2b	CHF 157.30	PE33.6x	E16.9%	2.0%
TECN Tecan Group	CHF 238.00	4.5%	-28.4%	CHF 3.1b	CHF 283.83	PE30.1x	E13.9%	1.3%
MER Merck KGaA	CHF 132.78	0%	n/a	CHF 64.6b	CHF 164.19	PE23.9x	E10.3%	1.5%

Page 1 of 2